COVID-19 Screenings: Employment, Healthcare and Regulatory Perspectives

May 21, 2020 | Duane Morris LLP | Webinar

Webinar Replay

About the Program

As states coordinate the reopening of the country, employers are planning how to respond to requirements and restrictions in order to resume business activities. Among many factors, this includes COVID-19 screenings, which present a wide range of implications. This webinar will discuss the COVID-19 screening process from different legal perspectives, including:

  • Employment—Confidentiality concerns/requirements for screening and results (under ADA), wage/hour issues related to screening processes (both if on-site and off-site), OSHA implications (general duty clause), handling a refusal to be screened and employment implications of a positive result.
  • Healthcare—Liability, health information privacy and HIPAA rules, reimbursement and other issues.
  • Regulatory—Types of different screenings, how to ensure FDA compliance and validation for the screening tools.


Patrick C. Gallagher, Ph.D., Partner and Team Lead,Life Sciences and Medical Technologies Industry Group


Rick Ball, Partner and Team Lead, Life Sciences and Medical Technologies Industry Group

Erin Duffy, Partner, Health Law Practice Group

Christopher Durham, Partner,Employment, Labor, Benefits and Immigration Practice Group

About Duane Morris

The Duane Morris COVID-19 Strategy Team advises clients on all aspects of the legal issues and implications of the COVID-19 (coronavirus disease 2019) pandemic, including contractual, employment, insurance and healthcare issues.

Duane Morris LLP, a law firm with more than 800 attorneys in offices across the United States and internationally, is asked by a broad array of clients to provide innovative solutions to today’s legal and business challenges.